Euclidean Capital

Funding rounds backed by Euclidean Capital.

Export CSV
Funding disclosed in full
$107M
Median round
$53.5M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Leal Therapeutics

Develops neuro-metabolic therapeutics for schizophrenia and ALS

$30MSeries ABiotechUnited States
8 participantsAlexandria Venture InvestmentsChugai Venture FundEli Lilly and CompanyEuclidean CapitalNewpath PartnersOrbiMedPhiFundSV Health Investors' Dementia Discovery Fund
InduPro

Develops proximity-guided antibody-drug conjugate therapeutics for cancer and autoimmune disease

$77MSeries BBiotechUnited States
8 participantsEli Lilly and CompanyEmerson CollectiveEuclidean CapitalMRL Ventures FundSanofiSolasta VenturesThe Column GroupVida Ventures